Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yizhi Anshen is a **traditional Chinese medicine herbal compound** developed by **Yiling Pharmaceutical** for cognitive and sleep-related disorders, particularly **amnestic mild cognitive impairment** and impaired sleep quality in older adults. It has been studied as both **granules** and **tablets**, and includes **Alpinia oxyphylla** among its herbal ingredients. Based on the available descriptions, its proposed pharmacology is not defined by a single molecular target; instead, it is intended under TCM theory to improve forgetfulness and sleep disturbance, with published work suggesting a **gut microbiome-modulating** effect that may alter microbial abundance and diversity and thereby contribute to cognitive and sleep benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yizhi Anshen.